These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 17828650)
1. The rise and fall of mood stabilizers. Malhi GS; Goodwin GM Aust N Z J Psychiatry; 2007 Oct; 41(10):779-83. PubMed ID: 17828650 [No Abstract] [Full Text] [Related]
2. Low-dose buspirone, melatonin and low-dose bupropion added to mood stabilizers for severe treatment-resistant bipolar depression. Nierenberg AA Psychother Psychosom; 2009; 78(6):391-3. PubMed ID: 19738411 [No Abstract] [Full Text] [Related]
3. [Fifty years of pharmacotherapy of mood disorders: have the expectations been fulfilled?]. Nolen WA Tijdschr Psychiatr; 2008; 50 Spec no.():111-6. PubMed ID: 19067309 [TBL] [Abstract][Full Text] [Related]
7. A case series on the hypothesized connection between dementia and bipolar spectrum disorders: bipolar type VI? Ng B; Camacho A; Lara DR; Brunstein MG; Pinto OC; Akiskal HS J Affect Disord; 2008 Apr; 107(1-3):307-15. PubMed ID: 17889374 [TBL] [Abstract][Full Text] [Related]
8. Pharmacologic induction of cholinergic system up-regulation and supersensitivity in affective disorders research. Dilsaver SC J Clin Psychopharmacol; 1986 Apr; 6(2):65-74. PubMed ID: 3517080 [TBL] [Abstract][Full Text] [Related]
9. Progress in the therapy of mood disorders: scientific support. Frank E; Kupfer DJ Am J Psychiatry; 2003 Jul; 160(7):1207-8. PubMed ID: 12832231 [No Abstract] [Full Text] [Related]
10. Antidepressant-induced mood conversions in bipolar disorder: a retrospective study of tricyclic versus non-tricyclic antidepressant drugs. Koszewska I; Rybakowski JK Neuropsychobiology; 2009; 59(1):12-6. PubMed ID: 19221443 [TBL] [Abstract][Full Text] [Related]
11. [Affective syndromes are fatal--the risk of suicide is high]. Runeson B; Haglund A Lakartidningen; 2013 Feb 27-Mar 12; 110(9-10):478-9. PubMed ID: 23540029 [No Abstract] [Full Text] [Related]
13. Effectiveness and safety of adjunctive antidepressants in the treatment of bipolar depression: a review. Harel EV; Levkovitz Y Isr J Psychiatry Relat Sci; 2008; 45(2):121-8. PubMed ID: 18982838 [TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of antidepressants and mood stabilizers. Serretti A; Gibiino S; Olgiati P Handb Clin Neurol; 2012; 106():715-44. PubMed ID: 22608654 [No Abstract] [Full Text] [Related]
17. Antidepressants and adolescents: the bipolar confound? Berk M; Dodd S Hum Psychopharmacol; 2005 Jan; 20(1):1-2. PubMed ID: 15614839 [No Abstract] [Full Text] [Related]
18. [Deficiencies and needs in the use of tricyclic antidepressive agents]. Deniker P; Ginestet D Therapie; 1973; 28(2):235-48. PubMed ID: 4766357 [No Abstract] [Full Text] [Related]
19. N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial. Berk M; Copolov DL; Dean O; Lu K; Jeavons S; Schapkaitz I; Anderson-Hunt M; Bush AI Biol Psychiatry; 2008 Sep; 64(6):468-75. PubMed ID: 18534556 [TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms in the actions of drugs active in mania and depression. A symposium: Collegium Internationale Neuropsychopharmacologicum (C.I.N.P.) Congress, Jerusalem, Israel, 20-25 June 1982. Neuropharmacology; 1983 Mar; 22(3 Spec No):359-446. PubMed ID: 6856047 [No Abstract] [Full Text] [Related] [Next] [New Search]